NIH-funded research R01 grant

Continuous glucose monitoring during pregnancy for people with type 2 diabetes

Official title: Continuous glucose monitoring for management of type 2 diabetes in pregnancy (CGM2 trial)

Funded at University of Alabama at Birmingham · NIH-11192784 · Data updated 2026-11-12

This project tests whether wearing a continuous glucose monitor helps pregnant people with type 2 diabetes keep blood sugar in range and have healthier outcomes for themselves and their babies.

More Diabetes research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Alabama at Birmingham
NIH-funded
Lab location1 site (Birmingham, United States)
Project startSeptember 13, 2024
Project endJuly 31, 2029
Funding year2025
Award (this year)$754,595
NIH project number5R01HD113612-02
Project IDNIH-11192784 on NIH RePORTER

Who could benefit from this research

Could help

Pregnant people who have preexisting type 2 diabetes and are receiving prenatal care would be ideal candidates.

Less likely to help

People with type 1 diabetes, those with only gestational diabetes, or individuals who cannot use wearable glucose devices are unlikely to benefit from this specific study.

What this research studies

If you join, you would be asked to use a continuous glucose monitor during pregnancy and follow regular prenatal care with study visits to collect glucose and health information. The trial compares CGM use to usual fingerstick blood glucose monitoring and tracks both maternal and newborn outcomes such as glucose control, birth complications, and newborn health. Researchers will also look at what percent of glucose readings should be in the target range for people with type 2 diabetes in pregnancy. The study will pay attention to social and structural factors that affect diabetes care to try to help groups with worse outcomes.

Why it matters

Potential benefit: If successful, this could make daily blood sugar control easier in pregnancy and reduce complications for mothers and newborns.

How similar studies have gone: Similar trials in type 1 diabetes pregnancies showed better glucose control and fewer newborn complications, but CGM use specifically in type 2 diabetes pregnancies is not well studied.

Where this research is happening

  • University of Alabama at Birmingham
    Birmingham, United States
    Active

Researchers

  • Principal investigator: Battarbee, Ashley Nicole — University of Alabama at Birmingham
  • Study coordinator: Battarbee, Ashley Nicole

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.